Please assess the completion status of the following clinical trial:

Trial Title: Virtual Reality in SOD

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of chronic biliary type abdominal pain (RUQ pain, pain radiates to the right flank, scapula, or shoulder, or pain that stimulates gallbladder symptoms)~* Pancreatic pain (epigastric or left upper quadrant pain, pain that is exacerbated by some food, or pain that radiates to the back) for at least 3 months prior to the study~* absence of abnormal liver and pancreas chemistry or abnormal abdominal imaging~* average pain score of greater than or equal to 3 out of 10 on the numeric rating scale (NRS) for at least the average of 3 episodes each week~* Subjects on antidepressants for pain control should take the medication for a minimum of one month prior to the baseline assessment.~* Patients with SOD with depressive and/or anxiety disorders who receive psychopharmacologic treatment must be on stable medication dose for at least 6 weeks.~* Patients with access to a cell phone, able to speak, read, and write English will be enrolled.~Exclusion Criteria:~* Patients with evidence for acute or chronic pancreatitis, biliary stones, or bile duct strictures.~* Patients who have had prior sphincterotomy must have had the procedure at 3 months prior to the start of the study.~* Patients with a history of motion sickness and vertigo and anyone experiencing active nausea or vomiting (including pregnant women) will be excluded.~* Patients with a history of seizures or epilepsy will also be excluded to limit the theoretical risk of inducing seizures with VR.~* Presence of significant psychiatric disorders or any conditions that, in the investigator's opinion make the subject unsuitable for study participation will be reason for exclusion.~* Non-English speaking subjects or subjects unable to consent to study due to cognitive difficulty will not be included in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Virtual Reality (Type: EXPERIMENTAL): Every participant is provided with a VR headset

Based on this trial design, predict the completion outcome and termination type (if applicable).